BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
SLQT
SelectQuote, Inc.
There isn't enough reported data to score SLQT yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
SLQT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
SLQT's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like SLQT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
SLQT PE Valuation
SLQT has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over SLQT on the outlook, with more favorable earnings and revenue expectations.
SLQT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect SLQT's revenue and profitability to decline, with its earnings holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus SLQT down 104%.
SLQT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.10 | +$0.22 |
| Q4 2024 | -$0.08 | +$0.23 |
| Q3 2024 | -$0.27 | +$0.01 |
| Q2 2024 | -$0.20 | +$0.15 |
| Q1 2024 | -$0.32 | +$0.38 |
| Q4 2023 | -$0.31 | +$0.49 |
| Q3 2023 | -$0.28 | +$1.50 |
| Q2 2023 | -$0.35 | +$1.45 |
SLQT is still losing money, but far less than before: $0.01 per share over the past year, against $1.80 at its worst in mid-2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over SLQT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over SLQT on profitability, with a higher operating margin.
SLQT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $280M | -15% |
| Q2 2026 | $321.7M | -6.8% |
| Q1 2026 | $430.9M | +5.6% |
| Q4 2025 | $537.1M | +12% |
| Q3 2025 | $328.8M | +13% |
| Q2 2025 | $345.1M | +12% |
| Q1 2025 | $408.2M | +8.4% |
| Q4 2024 | $481.1M | +19% |
SLQT's revenue grew through 2024 and has held roughly level since: $280M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +2.2 points |
| Q2 2026 | 1.1% | +4.7 points |
| Q1 2026 | 8.3% | +2.9 points |
| Q4 2025 | 14% | -0.7 points |
| Q3 2025 | -12% | -8.3 points |
| Q2 2025 | -3.6% | -3.2 points |
| Q1 2025 | 5.4% | -3.4 points |
| Q4 2024 | 15% | +1.1 points |
SLQT's operating margin was −10% last quarter, up 2.2 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
SLQT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.8M | +$4.8M |
| Q2 2026 | -$4.5M | +$33.5M |
| Q1 2026 | $55.8M | -20% |
| Q4 2025 | -$1M | +$28M |
| Q3 2025 | -$22.7M | -$5.6M |
| Q2 2025 | -$38M | -293% |
| Q1 2025 | $70.2M | +62% |
| Q4 2024 | -$29M | -$2M |
SLQT's free cash flow was $32M over the past year, against −$19M the year before. Free cash flow isn't a meaningful measure for financial services companies like SLQT.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over SLQT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
SLQT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +3.3M shares |
| 1 year | +3% | +5.6M shares |
| 3 years | +14% | +24M shares |
| 5 years | +17% | +27.8M shares |
| Available history | +39% | +53.3M shares |
SLQT has 191M diluted shares, up 3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
SLQT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 6.2x | High |
| Q3 2025 | 6.5x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 6.2x | High |
SLQT has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
SLQT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.3 | Neutral |
| Stochastic | 23.9 | Neutral |
SLQT's weekly RSI is 42 (neutral) and its Stochastic is 24 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
SLQT PE vs Financial Services Sector
| Metric | SLQT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
SLQT has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
SLQT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.39 | 26% above |
| 20 week MA | $0.55 | 11% below |
| 50 week MA | $0.84 | 42% below |
| 100 week MA | $1.81 | 73% below |
| 200 week MA | $1.90 | 74% below |
SLQT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 74% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over SLQT on returns for 2026, with the stronger performance.
SLQT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.5 | $22.3 | -16% |
| 2021 | $22.3 | $9.38 | -58% |
| 2022 | $9.38 | $0.65 | -93% |
| 2023 | $0.65 | $1.37 | +111% |
| 2024 | $1.37 | $3.68 | +169% |
| 2025 | $3.68 | $1.37 | -63% |
| 2026 YTD | $1.37 | $0.49 | -64% |
SLQT's yearly returns have swung widely, from +169% in 2024 to −93% in 2022. It's down 64% so far in 2026.